John Solomon @jsolomonReports
FDA cheerleads bivalent boosters, Paxlovid as research and 'rebounds' raise efficacy doubts | Just The News https://t.co/WXLQCzWhD8 — PolitiTweet.org
Created
Mon Nov 07 14:35:02 +0000 2022
Likes
54
Retweets
28
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
John Solomon @jsolomonReports
FDA cheerleads bivalent boosters, Paxlovid as research and 'rebounds' raise efficacy doubts | Just The News https://t.co/WXLQCzWhD8 — PolitiTweet.org